dideoxycytidin [Zalcitabine]
- Termíny
-
2',3'-Dideoxycytidine
ddC (Antiviral)
Dideoxycytidine
Hivid
HIVID Roche
NSC-606170
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy.
- DUI
- D016047 MeSH Prohlížeč
- CUI
- M0024532
- CAS
- Cytidine, 2',3'-dideoxy-
- Předchozí užití
- Dideoxynucleosides (1989); Deoxycytidine/analogs & derivatives (1986-1989)
- Historická pozn.
- 94; was DIDEOXYCYTIDINE 1990-93
- Online pozn.
- use ZALCITABINE to search DIDEOXYCYTIDINE 1990-93
- Veřejná pozn.
- 94; was DIDEOXYCYTIDINE 1990-93
Povolená podhesla
- AG
- agonisté
- AA
- analogy a deriváty 2
- AN
- analýza
- AI
- antagonisté a inhibitory
- AD
- aplikace a dávkování 3
- CS
- chemická syntéza
- CH
- chemie 2
- HI
- dějiny
- EC
- ekonomika
- PK
- farmakokinetika 2
- PD
- farmakologie 4
- IM
- imunologie
- IP
- izolace a purifikace
- CL
- klasifikace
- BL
- krev
- ME
- metabolismus
- UR
- moč
- CF
- mozkomíšní mok
- ST
- normy
- PO
- otrava
- AE
- škodlivé účinky 2
- TU
- terapeutické užití 5
- TO
- toxicita
- RE
- účinky záření
- SD
- zásobování a distribuce